OMH Osmetech

 

TIDMOMH 
 
RNS Number : 0005D 
Osmetech PLC 
24 November 2009 
 

24 November 2009 
 
 
Change in Details of a Director 
 
 
Osmetech PLC ("Osmetech" or "the Company") (AIM: OMH) announces that it was 
notified on 23 November 2009 that Jon Faiz Kayyem is no longer a Managing 
Partner of Efficacy Capital Limited ("Efficacy"). 
 
 
Since the announcement made by the Company on 1 July 2009, Efficacy's aggregate 
interest in the Osmetech ordinary 0.1p shares remains unchanged at 307,200,049. 
 
 
 
Efficacy is the manager of the Efficacy Biotech Master Funds and Dr. 
Kayyem's beneficial interest in the Efficacy Biotech Master Funds also remains 
unchanged. 
 
 
Consequently, Dr. Kayyem's beneficial interest in Osmetech ordinary 0.1p shares 
remains unchanged and is held through the following registered holdings: 
 
 
+---------------------------------+---------------+----------------+ 
| Registered Owner                |     Number of |  % of issued   | 
|                                 |      ordinary | share capital  | 
|                                 |        shares |                | 
+---------------------------------+---------------+----------------+ 
| Efficacy Biotech Master Funds   |  109,698,822  |     9.51%      | 
+---------------------------------+---------------+----------------+ 
| IFIN LP                         |    3,714,300  |     0.32%      | 
+---------------------------------+---------------+----------------+ 
| Total                           |   113,413,122 |     9.83%      | 
+---------------------------------+---------------+----------------+ 
 
 
 
 
Save as disclosed above, and in accordance with AIM Rule 17, there is nothing 
further to disclose under Schedule Two, paragraph (g) of the AIM Rules. 
 
 
For further information: 
 
+----------------------------------+---------------------------------------------+ 
| Osmetech plc:                    | +44 (0) 20 7849 6027                        | 
+----------------------------------+---------------------------------------------+ 
| David Sandilands, Chief          |                                             | 
| Financial Officer                |                                             | 
+----------------------------------+---------------------------------------------+ 
|                                  |                                             | 
+----------------------------------+---------------------------------------------+ 
| Madano Partnership:              | +44 (0) 207 593 4000                        | 
+----------------------------------+---------------------------------------------+ 
| Matthew Moth                     |                                             | 
+----------------------------------+---------------------------------------------+ 
|                                  |                                             | 
+----------------------------------+---------------------------------------------+ 
| Canaccord Adams Limited:         | +44 (0) 20 7050 6500                        | 
+----------------------------------+---------------------------------------------+ 
| Robert Finlay                    |                                             | 
+----------------------------------+---------------------------------------------+ 
| Henry Fitzgerald-O'Connor        |                                             | 
+----------------------------------+---------------------------------------------+ 
 
 
 
 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 RDNFEUFELSUSEIF 
 

Osmetech (LSE:OMH)
Historical Stock Chart
From Dec 2024 to Jan 2025

Osmetech (LSE:OMH)
Historical Stock Chart
From Jan 2024 to Jan 2025